Xarelto Lawsuit Update: Lawsuits Allege Manufacturers Knew of Xarelto Dangers

October 05, 2015 – – BloodThinnerHelp.com reports on the allegations made by the recently filed Xarelto lawsuits. Many of the lawsuits filed allege that the manufacturers of Xarelto, Bayer AG and Janssen Pharmaceuticals, a subdivision of Johnson&Johnson, had prior knowledge of the dangers of the drug yet released the product to market anyway. For more detailed information on the Xarelto lawsuits, click here.

Xarelto was released onto the United States market in 2011 after receiving approval from the Food and Drug Administration, FDA, to treat atrial fibrillation, deep vein thrombosis, and for use in patients who have recently undergone knee or hip replacement surgeries.

As time passed, reports of adverse events occurring in patients who were also taking Xarelto began to pour in to the FDA. A Phase III study was performed recently on individuals who were taking Xarelto. The study found that the 73% of the 16,041 patients studied had suffered from an adverse event while taking Xarelto such as internal bleeding or anemia. After this study was performed, the FDA issued a warning regarding Xarelto in August 2013 that informed patients and doctors that ending a Xarelto regimen prematurely can lead to a higher risk of blood clots. Despite this warning and the Phase III study, the manufacturers of Xarelto made $1.4 billion in Xarelto sales in 2013. Xarelto also has two ‘black box’ warnings attached to it. A black box warning is the strictest warning the FDA can issue to a drug short of recalling it. For more on the warnings the FDA has issued about Xarelto, click here.

Xarelto Victims Filing Lawsuits:

The first Xarelto lawsuit was filed in January 2014. The first lawsuit alleged that Xarelto was the cause of the individual’s death due to complications from an uncontrollable internal bleed caused by Xarelto usage. Many of the lawsuits filed since then also allege that Xarelto causes uncontrollable internal bleeding events which can lead to serious injury or death. Further, the lawsuits allege that Xarelto’s manufacturers were aware of the dangers of the drug and released it to market anyway.

The Xarelto lawsuits that are filed federally have been consolidated into a federal multidistrict litigation, an MDL, in the United States District Court for the Eastern District of Louisiana located in New Orleans. Pretrial activities have been taking place since the creation of the MDL in December 2014 and the actual Xarelto trials are not scheduled to begin until early 2017.

“If it is found that the manufacturers of Xarelto did indeed have prior knowledge of the dangers of the drug and put it to market anyway, they deserve to be brought to justice.” Xarelto attorney Marc Goldich commented, “If you believe that you or a loved one were harmed by Xarelto, contact us immediately.”

For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.

ReleaseID: 60004561